We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+9.26%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+548.24%
AUM
$726B
AUM Growth
+$72B
Cap. Flow
+$18.3B
Cap. Flow %
2.52%
Top 10 Hldgs %
22.02%
Holding
4,790
New
331
Increased
3,384
Reduced
720
Closed
74

Sector Composition

Rank Sector Weight
1 Technology 23.98%
2 Financials 13.87%
3 Healthcare 13.39%
4 Consumer Discretionary 11.81%
5 Communication Services 10.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ATCO
3851
DELISTED
Atlas Corp.
ATCO
$604K ﹤0.01%
42,412
+22,786
+116% +$316K
OR icon
3852
OR Royalties Inc
OR
$5.58B
$603K ﹤0.01%
44,050
+10,622
+32% +$142K
CYPH
3853
Cypherpunk Technologies Inc
CYPH
$62.9M
$602K ﹤0.01%
36,732
+1,788
+5% +$30.2K
MAXN
3854
DELISTED
Maxeon Solar Technologies
MAXN
$601K ﹤0.01%
280
-726
-72% -$1.36M
LSTA icon
3855
Lisata Therapeutics
LSTA
$9.02M
$599K ﹤0.01%
24,835
+3,625
+17% +$85.9K
ACCS
3856
ACCESS Newswire
ACCS
$25.6M
$599K ﹤0.01%
22,095
+2,290
+12% +$59.1K
PTE
3857
DELISTED
PolarityTE, Inc. Common Stock
PTE
$599K ﹤0.01%
23,526
+10,213
+77% +$269K
GGAL icon
3858
Galicia Financial Group
GGAL
$7.99B
$597K ﹤0.01%
69,368
+12,319
+22% +$104K
DMAC icon
3859
DiaMedica Therapeutics
DMAC
$342M
$594K ﹤0.01%
133,569
+5,101
+4% +$41.8K
CHRN
3860
ChronoScale Holdings
CHRN
$3.2B
$594K ﹤0.01%
7,208
+2,861
+66% +$241K
CGAU
3861
Centerra Gold
CGAU
$3.36B
$591K ﹤0.01%
+74,237
New +$617K
TRAK icon
3862
ReposiTrak
TRAK
$153M
$588K ﹤0.01%
106,778
-77,609
-42% -$441K
AUDC icon
3863
AudioCodes
AUDC
$244M
$587K ﹤0.01%
17,740
+659
+4% +$21K
CRVO icon
3864
CervoMed
CRVO
$23.9M
$587K ﹤0.01%
10,724
+1,390
+15% +$76.8K
CCLD icon
3865
CareCloud
CCLD
$104M
$586K ﹤0.01%
69,644
+10,536
+18% +$87.5K
DARE icon
3866
Dare Bioscience
DARE
$18.3M
$586K ﹤0.01%
25,860
+4,256
+20% +$72.7K
NAII icon
3867
Natural Alternatives International
NAII
$14.4M
$586K ﹤0.01%
34,627
+4,517
+15% +$67K
KVSC
3868
DELISTED
Khosla Ventures Acquisition Co. III Class A Common Stock
KVSC
$586K ﹤0.01%
+59,286
New +$595K
ISAA
3869
DELISTED
Iron Spark I Inc. Class A Common Stock
ISAA
$586K ﹤0.01%
+58,740
New +$585K
LOGC
3870
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$586K ﹤0.01%
132,121
-97,294
-42% -$495K
EGO icon
3871
Eldorado Gold
EGO
$7.87B
$584K ﹤0.01%
55,543
+6,006
+12% +$66.9K
HCIC
3872
DELISTED
Hennessy Capital Investment Corp. V Class A Common Stock
HCIC
$579K ﹤0.01%
+57,321
New +$569K
ORGN
3873
DELISTED
Origin Materials
ORGN
$578K ﹤0.01%
+2,352
New +$700K
TOVX icon
3874
Theriva Biologics
TOVX
$9.64M
$576K ﹤0.01%
3,825
+383
+11% +$54.9K
HHR
3875
DELISTED
HeadHunter Group PLC American Depositary Shares
HHR
$576K ﹤0.01%
13,600
+1,311
+11% +$50.6K

Similar funds

Geode Capital Management's Q2 2021 Portfolio in Review

As of Q2 2021, Geode Capital Management held 4,790 positions worth $726B, up 11% from $654B the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Geode Capital Management's Q2 2021 filing shows 331 new, 3,384 increased, 720 reduced and 74 closed positions. Its largest new stake was Organon & Co: 5,070,121 shares worth $153M. The largest sale was Sherwin-Williams, an estimated $1.88B.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

  • Geode Capital Management's largest Q2 2021 buy was Organon & Co: 5,070,121 shares worth $153M.
  • Geode Capital Management added most to Microsoft in Q2 2021, an estimated $786M increase.
  • Geode Capital Management's biggest Q2 2021 reduction was Sherwin-Williams, cutting an estimated $1.88B.
  • Geode Capital Management fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $274M.
  • Geode Capital Management's ten largest holdings make up 22% of its $726B portfolio in Q2 2021.
  • Geode Capital Management opened 331 new positions and closed 74 in Q2 2021.
  • Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $726B.

Based on Geode Capital Management's 13F filing for Q2 2021, filed 13 Aug 2021.